Superior Planning, LLC’s Krystal Biotech KRYS Stock Holding History

Superior Planning, LLC’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.33K	Buy	+7	New	+$2.42K	﹤0.01%	1509

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Superior Planning, LLC's KRYS Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Krystal Biotech (KRYS) in Q3 2026: 7 shares worth $2.33K. The stake represents ﹤0.01% of the portfolio and ranks #1509 among its holdings.

295 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

Superior Planning, LLC held 7 shares of Krystal Biotech worth $2.33K as of Q3 2026.
Krystal Biotech was a new Superior Planning, LLC position in Q3 2026.
Krystal Biotech made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1509 holding.
295 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.